Valeant Pharmaceuticals International Inc. / Valeant Pharmaceuticals Intern / /
Country
United States / /
Event
Employment Change / FDA Phase / /
IndustryTerm
healthcare marketplace / to all items and services / healthcare laws / healthcare industry / healthcare programs / federal healthcare program / healthcare conditions / pharmaceutical industry / pharmaceutical promotional and educational practices / federal healthcare programs / pharmaceutical manufacturers / healthcare / pharmaceutical / healthcare facility network / healthcare requirements / bona fide services / to items and services / healthcare plans / /
Organization
Promotional Review Committee / Congress / Accreditation Council for Continuing Medical Education / PhRMA / Food and Drug Administration / Indian Health Service / Council on Ethical and Judicial Affairs Clarification of Gifts / American Medical Association / Department of Veterans Affairs / Department of Health and Human Services / Risk Committee of Valeant / Pharmaceutical Research and Manufacturers Association / Advanced Medical Technology Association / office of the Inspector General / Legal Department / Compliance Department / Medicare / / /
Position
Chief Compliance Officer / supervisor / Vice President / Chief / Compliance Officer / speaker / Vice President / Chief Compliance Officer / Chief Executive Officer / U.S. Compliance Officer / nurse / physician / manager / supervisor / VP / Chief Compliance Officer / Accreditation Counsel / Vice President / Chief Compliance Officer and U.S. Compliance Officer / Executive Vice President / General Counsel / supervisor / the Vice President / Chief Compliance Officer / the U.S. Compliance Officer / /
HEALTHCARE COMPLIANCE POLICY Effective Date: May 20, 2013 Version: 3 Policy No.: VRX-US-CMP-001 Approved by: VP, Chief Compliance Officer and